Microbot LIBERTY System Cuts Radiation Exposure 92%, Full Release April 2026
The AMA adopted a new policy in late 2025 to strengthen protections for healthcare professionals from ionizing radiation. Microbot’s LIBERTY Endovascular Robotic System, launched in limited release late 2025, showed a 92% reduction in radiation exposure and is slated for full market release in April 2026.
1. AMA Expands Radiation Protection Policy
The American Medical Association adopted a new policy in late 2025 to enhance protections for healthcare professionals and trainees from cumulative ionizing radiation exposure, emphasizing research into health effects, personal protective equipment efficacy, and improved education and training.
2. LIBERTY System Demonstrates 92% Exposure Reduction
Microbot’s LIBERTY Endovascular Robotic System, remotely operated to allow physicians to work away from radiation sources, achieved a 92% relative reduction in exposure during the ACCESS-PVI study, highlighting its potential to improve safety in interventional procedures.
3. Market Release Timeline and Growth Outlook
Following a limited market release in late 2025, Microbot plans a full market roll-out of LIBERTY at the Society of Interventional Radiology conference in April 2026, aiming to address staffing shortages and drive adoption by reducing both radiation and musculoskeletal strain.